Loading…
Loading…
DYNT (Dynatronics Corporation) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
DYNT does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for DYNT and 80,000+ other tickers.
See exactly how DYNT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DYNT and 80,000+ other tickers.
Dynatronics Corporation functions as a medical device firm dedicated to the creation, production, and distribution of essential products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. While its primary market is the United States, the company also exports its goods to approximately 30 international locations. The company's diverse product range includes an extensive selection of orthopedic soft bracing solutions, such as cervical collars, shoulder immobilizers, arm slings, supports for wrists, elbows, abdominals, and lumbosacral regions, as well as…
LivaNova (NASDAQ: LIVN - Get Free Report) and Dynatronics (NASDAQ: DYNT - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Risk and Volatility LivaNova has a beta of 0.86, indicating
Earnings and Valuation This table compares Dynatronics and Interpace Biosciences"s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dynatronics $33.60 million 0.00 -$2.70 million ($1.35) -0.01 Interpace Biosciences $38.73 million 0.23 $24.58 million ($0.02) -99.88 Interpace Biosciences has higher revenue and earnings than Dynatronics. Interpace
Dynatronics Co. (NASDAQ: DYNT - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $0.04 and traded as low as $0.0080. Dynatronics shares last traded at $0.0080, with a volume of 502 shares changing hands. Dynatronics Stock
Dynatronics Co. (NASDAQ: DYNT - Get Free Report)'s share price passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.06 and traded as low as $0.01. Dynatronics shares last traded at $0.01, with a volume of 21,864 shares trading hands. Dynatronics Stock Down 32.9% The company
Dynatronics Co. (NASDAQ: DYNT - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.07 and traded as low as $0.0455. Dynatronics shares last traded at $0.0455, with a volume of 27,122 shares trading hands. Dynatronics Trading Down 7.7% The company